Stay updated on Empagliflozin for Heart Attack Patients Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin for Heart Attack Patients Clinical Trial page.

Latest updates to the Empagliflozin for Heart Attack Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check39 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check61 days agoChange DetectedThe website has updated the intervention type and posted new results as of January 7, 2025, while removing the previous submission from November 14, 2023.SummaryDifference2%
- Check90 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to Empagliflozin for Heart Attack Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin for Heart Attack Patients Clinical Trial page.